Canonical ingredient
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester
NIFEDIPINE
64 linked products
Official identifiers
Names and synonyms
- 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester (en)
- nifedipine (en)
- Nifédipine (fr)
- Nifedipine (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
ADALAT
5 · MG
ADALAT - CAP 10MG
10 · MG
ADALAT CAP 10MG
10 · MG
ADALAT CAP 5MG
5 · MG
ADALAT OROS
20 · MG
ADALAT OROS
30 · MG
ADALAT OROS
60 · MG
ADALAT P.A.10 -SRT 10MG
10 · MG
ADALAT P.A.20 -SRT 20MG
20 · MG
ADALAT PA 10 TAB 10MG
10 · MG
ADALAT PA 20
20 · MG
ADALAT XL
30 · MG
ADALAT XL
60 · MG
ADALAT XL
20 · MG
ADALAT XL PLUS
20 · MG
ADALAT XL PLUS
30 · MG
ADALAT XL PLUS
60 · MG
ADALAT XL TAB 30MG
30 · MG
ADALAT XL TAB 60MG
60 · MG
AG-NIFEDIPINE ER
60 · MG
APO-NIFED PA
20 · MG
APO-NIFED PA
10 · MG
DOM-NIFEDIPINE
5 · MG · CAP
DOM-NIFEDIPINE
10 · MG · CAP
GEN NIFEDIPINE CAP 10MG USP
10 · MG
JAMP NIFEDIPINE ER
60 · MG
M-NIFEDIPINE ER
60 · MG
MAR-NIFEDIPINE ER
60 · MG
MYLAN-NIFEDIPINE EXTENDED RELEASE
60 · MG
MYLAN-NIFEDIPINE EXTENDED RELEASE
30 · MG
MYLAN-NIFEDIPINE EXTENDED RELEASE
20 · MG
NIFEDIPINE
5 · MG
NIFEDIPINE
10 · MG
NIFEDIPINE 10MG - CAP
10 · MG · CAP
NIFEDIPINE 5MG - CAP
5 · MG · CAP
NIFEDIPINE CAPSULES 10MG
10 · MG · CAP
NIFEDIPINE ER
30 · MG
NIFEDIPINE ER
60 · MG
NIFEDIPINE ER
20 · MG
NIFEDIPINE ER
30 · MG
NIFEDIPINE ER
60 · MG
NIFEDIPINE PA -10 - SRT 10MG
10 · MG · SRT
NIFEDIPINE PA 10 - SRT 10MG
10 · MG · SRT
NIFEDIPINE PA 20 - SRT 20MG
20 · MG · SRT
NIFEDIPINE PA-20 - SRT 20MG
20 · MG · SRT
NIFEDIPINE-10 CAP 10MG
10 · MG · CAP
NOVO-NIFEDIN CAP 10MG
10 · MG · CAP
NOVO-NIFEDIN CAP 5MG
5 · MG · CAP